Cite
HARVARD Citation
Hsu, B. et al. (n.d.). FRI0181 Sirukumab, a human anti-IL-6 monoclonal antibody, improves physical function in patients with active ra despite methotrexate therapy: Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study. Annals of the rheumatic diseases. p. 373. [Online].